The American Diabetes Association (ADA) announced the formal endorsement of three bills aiming to reduce the high cost of insulin and prescription drugs.
The Insulin Price Reduction Act will reduce rising insulin costs by providing incentives for manufacturers to revert the 2006 list price of all insulin products.
The Safe Step Act will remove barriers to good diabetes management and prevent the delay of treatment for people with diabetes due to “step therapy,” in which a health plan can require patients to try a drug before they pay for one prescribed by the patient’s healthcare provider.
The Chronic Condition Copay Elimination Act will remove copays for certain items and services to treat chronic conditions.
“More than 5,000 bills and resolutions are introduced annually into Congress, and if we want to truly help people with diabetes thrive, we must cut to the chase and make it clear which bills truly impact their lives,” said Tracey D. Brown, CEO of the American Diabetes Association.